Genocore-Biotech.com Announce Advance Long-Acting Hemophilia B Therapy into a Registrational Trial

genocore-biotech.com

Genocore-Biotech.com Announce Advance Long-Acting Hemophilia B Therapy into a Registrational Trial

2015-12-29 // 0 Comments

Shenzhen, China, December 29, 2015 — /EPR NETWORK/ — Genocore Biotech (ISIN:CN1000007515), an innovation-driven biopharmaceutical company focused on development and commercialization of therapeutic monoclonal antibody (mAbs), today [read full press release…]

Genocore-Biotech.com Foundation Announces $250.000 Gift to Biotechnology Center

2015-12-28 // 0 Comments

Shenzhen; China, December 28, 2015 — /EPR NETWORK/ — Genocore Biotech (ISIN:CN1000007515), an innovation-driven biopharmaceutical company focused on development and commercialization of therapeutic monoclonal antibody (mAbs), today announced [read full press release…]